Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CRYSTAL Study: Cryodevitalization Study for the Treatment of Early-Stage Lung Cancer

NCT06593106 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT06593106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06593106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CRYSTAL Study: Cryodevitalization Study for the Treatment of Early-Stage Lung Cancer
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 27, 2024
Completion date
August 31, 2027
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage i lung cancer, stage ii lung cancer